Raymond Wadlow MD (@raymondwadlowmd) 's Twitter Profile
Raymond Wadlow MD

@raymondwadlowmd

Co-Director, Gastrointestinal Oncology Research and Program Director, Hematology-Oncology Fellowship, Inova Schar Cancer Institute

ID: 784020367677480960

calendar_today06-10-2016 13:19:56

71 Tweet

285 Followers

455 Following

donnashort (@donnashort) 's Twitter Profile Photo

Most prevalent #GImalignancy after #colorectal is #NETs and the incidence is rising says Yoomi LeeOncLive SOSS⁩ #ipc #mom with chair ⁦Raymond Wadlow MD⁩ ⁦Inova Schar Cancer Institute⁩ patients with a lower Ki67 got more benefit out of lanreotide. PRRT used in NETTER1 w/RR18%

Most prevalent #GImalignancy after #colorectal is #NETs and the incidence is rising says <a href="/yoomilee10/">Yoomi Lee</a> ⁦<a href="/OncLiveSOSS/">OncLive SOSS</a>⁩ #ipc #mom with chair ⁦<a href="/RaymondWadlowMD/">Raymond Wadlow MD</a>⁩ ⁦<a href="/InovaSchar/">Inova Schar Cancer Institute</a>⁩ patients with a lower Ki67 got more benefit out of lanreotide. PRRT used in NETTER1 w/RR18%
donnashort (@donnashort) 's Twitter Profile Photo

Still a very deadly disease #pancreaticcancer with no readily available screening process and tends to present with symptoms and therefore advanced says ⁦Raymond Wadlow MD⁩ chair ⁦OncLive SOSS⁩ #ipc ⁦Inova Schar Cancer Institute⁩ #gism litany of failed efforts in trials. #sadness

Still a very deadly disease #pancreaticcancer with no readily available screening process and tends to present with symptoms and therefore advanced says ⁦<a href="/RaymondWadlowMD/">Raymond Wadlow MD</a>⁩ chair ⁦<a href="/OncLiveSOSS/">OncLive SOSS</a>⁩ #ipc ⁦<a href="/InovaSchar/">Inova Schar Cancer Institute</a>⁩ #gism litany of failed efforts in trials. #sadness
donnashort (@donnashort) 's Twitter Profile Photo

Rapidly changing field of #hcc according to ⁦arthur winer⁩ the sixth most common cancer worldwide and rising in the US ⁦OncLive SOSS⁩ #ipc chair ⁦Raymond Wadlow MD⁩ ⁦Inova Schar Cancer Institute⁩ targeting the liver and tumors blood supply is a valid target. ?immune chkpt i

Rapidly changing field of #hcc according to ⁦<a href="/arthurwiner/">arthur winer</a>⁩ the sixth most common cancer worldwide and rising in the US ⁦<a href="/OncLiveSOSS/">OncLive SOSS</a>⁩ #ipc chair ⁦<a href="/RaymondWadlowMD/">Raymond Wadlow MD</a>⁩ ⁦<a href="/InovaSchar/">Inova Schar Cancer Institute</a>⁩ targeting the liver and tumors blood supply is a valid target. ?immune chkpt i
donnashort (@donnashort) 's Twitter Profile Photo

What impact does the diagnosis of a #gastrointestinalcancer diagnosis have on a patient’s psycho/social wellbeing asks ⁦Jennifer Bires⁩ ⁦OncLive SOSS⁩ #ipc with chair ⁦Raymond Wadlow MD⁩ ⁦Inova Schar Cancer Institute⁩ there is a life with #cancer program at Inova

What impact does the diagnosis of a #gastrointestinalcancer diagnosis have on a patient’s psycho/social wellbeing asks ⁦<a href="/JenniferBires/">Jennifer Bires</a>⁩ ⁦<a href="/OncLiveSOSS/">OncLive SOSS</a>⁩ #ipc with chair ⁦<a href="/RaymondWadlowMD/">Raymond Wadlow MD</a>⁩ ⁦<a href="/InovaSchar/">Inova Schar Cancer Institute</a>⁩ there is a life with #cancer program at Inova
donnashort (@donnashort) 's Twitter Profile Photo

Experts from ⁦Inova Schar Cancer Institute⁩ answer questions from the community on #gicancers ⁦OncLive SOSS⁩ #ipc chair ⁦Raymond Wadlow MD⁩ with ⁦arthur winerYoomi LeeJennifer Bires⁩ increase in younger patients receiving diagnosis of #colorectalcancer #sadness

Experts from ⁦<a href="/InovaSchar/">Inova Schar Cancer Institute</a>⁩ answer questions from the community on #gicancers ⁦<a href="/OncLiveSOSS/">OncLive SOSS</a>⁩ #ipc chair ⁦<a href="/RaymondWadlowMD/">Raymond Wadlow MD</a>⁩ with ⁦<a href="/arthurwiner/">arthur winer</a>⁩ <a href="/yoomilee10/">Yoomi Lee</a> ⁦<a href="/JenniferBires/">Jennifer Bires</a>⁩ increase in younger patients receiving diagnosis of #colorectalcancer #sadness
Raymond Wadlow MD (@raymondwadlowmd) 's Twitter Profile Photo

Drug Approvals in Hepatocellular Carcinoma ja.ma/3aAJhyO via JAMA Oncology part of JAMA Network Options are great, but patients deserve studies designed with a more holistic understanding of the treatment landscape

Raymond Wadlow MD (@raymondwadlowmd) 's Twitter Profile Photo

Enjoyed #ACGME2021 session for new program directors with invaluable info on CCCs, Milestones, PECs and more from Natasha Bray @dr_c_cable and colleagues

Inova Schar Cancer Institute (@inovaschar) 's Twitter Profile Photo

Today we are celebrating #RegisteredDietitian Nutritionist Day! Did you know there are only 25 dietitians in the state of Virginia with the elite distinction of being board Certified Specialists in Oncology Nutrition? We are fortunate enough to have SIX of them!

Today we are celebrating #RegisteredDietitian Nutritionist Day! Did you know there are only 25 dietitians in the state of Virginia with the elite distinction of being board Certified Specialists in Oncology Nutrition? We are fortunate enough to have SIX of them!
Raymond Wadlow MD (@raymondwadlowmd) 's Twitter Profile Photo

“(Berry) found that in neighborhoods where 90 percent or more of the residents are Black, homes are taxed roughly 50% higher than they are in other neighborhoods in the same county..’This is an example of structural racism’ washingtonpost.com/business/2021/…

Daniel Gerlach (@gerlach_d) 's Twitter Profile Photo

The KRAS G12C inhibitor JDQ443 from Novartis inhibits the double mutant (KRAS G12C H95Q) mediating resistance to adagrasib in clinical trials. #Targets21

The KRAS G12C inhibitor JDQ443 from Novartis inhibits the double mutant (KRAS G12C H95Q) mediating resistance to adagrasib in clinical trials. #Targets21
Keith Hornberger (@krhornberger) 's Twitter Profile Photo

❗️BREAKING at AACR #Targets21: Mirati Therapeutics has disclosed the structure of MRTX1133, their reversible KRAS G12D inhibitor. Fantastic story. Plus hints of a new pan-KRAS inhibitor. Congratulations!

❗️BREAKING at <a href="/AACR/">AACR</a> #Targets21: Mirati Therapeutics has disclosed the structure of MRTX1133, their reversible KRAS G12D inhibitor. Fantastic story. Plus hints of a new pan-KRAS inhibitor. Congratulations!
Mark Yarchoan (@markyarchoan) 's Twitter Profile Photo

About 2/3 of patients receiving reversible FGFR2 inh (eg pemigatinib) develop 2nd resistance mut. Emerging data suggest a role for futibatinib and other novel agents (eg RLY-4008). Similar to ALK (crizotinib->alectinib->lorlatinib)

About 2/3 of patients receiving reversible FGFR2 inh (eg pemigatinib) develop 2nd resistance mut. Emerging data suggest a role for futibatinib and other novel agents (eg RLY-4008). Similar to ALK (crizotinib-&gt;alectinib-&gt;lorlatinib)
Raymond Wadlow MD (@raymondwadlowmd) 's Twitter Profile Photo

Skip Primary Resection for Asymptomatic CRC With Unresectable Metastases? medpagetoday.com/hematologyonco…. Emphasizing the importance of multidisciplinary evaluation by specialists in colorectal cancer

Raymond Wadlow MD (@raymondwadlowmd) 's Twitter Profile Photo

Just finished Bellow’s Augie March and for fun decided to name the 5 greatest American novels, my opinion only, and limited to 10:47 on 10/16/21, not in order either: Augie, All The King’s Men, Native Son, Beloved and Infinite Jest. Tell me I’m wrong…

Aparna Raj Parikh (@aparna1024) 's Twitter Profile Photo

#equityintrials This came up this week re neutropenia criteria. 10% of black patients have benign hereditary neutropenia and pt excluded if threshold is set at 1500. given no sponsor wiggle room! National Cancer Institute Dr. Cathy Eng Karyn Goodman, MD, MS SWOG Cancer Research Network ECOG-ACRIN Cancer Research Group systematic ways to address?

Raymond Wadlow MD (@raymondwadlowmd) 's Twitter Profile Photo

"“We still do not know the genetic cause of pancreatic cancer in the majority of families with multiple members affected with the disease.” -Diane M. Simeone, MD" ascopost.com/issues/decembe… via The ASCO Post

Inova Schar Cancer Institute (@inovaschar) 's Twitter Profile Photo

Discover all classes, groups, and special events offered by Inova Peterson Life with Cancer on the new and improved calendar and registration website! Register for several FREE classes and groups from anywhere, anytime! Discover and register: events.lifewithcancer.org! #cancercare #cancersupport

Discover all classes, groups, and special events offered by 
<a href="/LifewithCancer/">Inova Peterson Life with Cancer</a> on the new and improved calendar and registration website! Register for several FREE classes and groups from anywhere, anytime!

Discover and register: events.lifewithcancer.org! #cancercare #cancersupport